P2.16-05 Durvalumab+EP in Advanced Large-Cell Neuroendocrine Carcinoma of Lung (aLCNEC): a Pilot Phase II study von Dudnik, E., Ariel, L., Hod, K., Nechushtan, H., Hanovich, E., Rotem, O., Wollner, M., Guindy, M., Ben David, M.A.

Volltext

Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome von Bart, Bradley A, Goldsmith, Steven R, Lee, Kerry L, Givertz, Michael M, O'Connor, Christopher M, Bull, David A, Redfield, Margaret M, Deswal, Anita, Rouleau, Jean L, LeWinter, Martin M, Ofili, Elizabeth O, Stevenson, Lynne W, Semigran, Marc J, Felker, G. Michael, Chen, Horng H, Hernandez, Adrian F, Anstrom, Kevin J, McNulty, Steven E, Velazquez, Eric J, Ibarra, Jenny C, Mascette, Alice M, Braunwald, Eugene

Volltext

Trial of abciximab with and without low-dose reteplase for acute myocardial infarction

Volltext

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention von AGUIRRE, F. V, TOPOL, E. J, ROSENBERG, M, DONOHUE, T. J, WEISMAN, H. F, CALIFF, R. M, FERGUSON, J. J, ANDERSON, K, BLANKENSHIP, J. C, HEUSER, R. R, SIGMON, K, TAYLOR, M, GOTTLIEB, R, HANOVICH, G

Volltext

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators von Aguirre, F V, Topol, E J, Ferguson, J J, Anderson, K, Blankenship, J C, Heuser, R R, Sigmon, K, Taylor, M, Gottlieb, R, Hanovich, G

Volltext